Company Filing History:
Years Active: 2010-2012
Title: Tulsidas More: Innovator in Pharmaceutical Chemistry
Introduction
Tulsidas More is a prominent inventor based in Mumbai, India, known for his significant contributions to pharmaceutical chemistry. He holds a total of five patents, showcasing his innovative approach to developing new medicinal compounds. His work primarily focuses on creating effective treatments for various health conditions.
Latest Patents
Among his latest patents, Tulsidas has developed tricyclic guanidine derivatives that act as sodium-proton exchange inhibitors. These compounds are particularly useful as medicaments for treating organ disorders associated with ischemia and reperfusion, cardiac arrhythmia, cardiac hypertrophy, hypertension, cell proliferative disorders, and diabetes. Another notable patent involves fused tricyclic compounds that serve as inhibitors of tumor necrosis factor-alpha (TNF-α). These compounds are designed to treat and prevent disorders caused by increased TNF-α activity, especially inflammations.
Career Highlights
Tulsidas More is currently associated with Piramal Life Sciences Limited, where he continues to push the boundaries of pharmaceutical research. His innovative work has garnered attention in the scientific community, contributing to advancements in medical treatments.
Collaborations
Tulsidas collaborates with talented professionals in his field, including Bansi Lal and Swati Bal-Tembe. Their combined expertise enhances the research and development efforts at Piramal Life Sciences Limited.
Conclusion
Tulsidas More's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work not only advances medical science but also offers hope for effective treatments for various health conditions.